๐ Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Asian Hotels (North) raises Rs 514.67 Cr via Equity and NCDs to address debt
Asian Hotels (North) has completed a significant capital raise of approximately Rs 514.67 Crores through equity and debt instruments. The company allotted 65.05 lakh equity shares to Elana Holdings at Rs 330 per share, raising Rs 214.67 Crores and increasing the investor's stake to 39.83%. Additionally, it raised Rs 300 Crores through 12.5% secured Non-Convertible Debentures (NCDs). This infusion is critical as the company disclosed an existing loan default of Rs 770.12 Crores as of December 31, 2025.
Key Highlights
Raised Rs 214.67 Crores via preferential allotment of 65.05 lakh equity shares at Rs 330 each to Elana Holdings PTE. LTD.
Elana Holdings' stake in the company has increased from 24.68% to 39.83% following the allotment.
Issued Rs 300 Crores worth of unlisted, senior, secured NCDs with a high coupon rate of 12.5% per annum.
Disclosed a substantial default on bank and financial institution loans amounting to Rs 770.12 Crores as of Dec 2025.
NCDs are secured by a first charge on the Hyatt Regency New Delhi property and have a 2-year maturity period.
๐ผ Action for Investors
Investors should closely monitor if this capital infusion is sufficient to restructure the Rs 770 Crore default and stabilize operations. The high cost of debt (12.5%) and significant equity dilution indicate a high-risk turnaround situation.
Elana Holdings Acquires 24.68% Stake in Asian Hotels (North) for โน210.34 Crore
Elana Holdings Pte Ltd has acquired a significant 24.68% stake in Asian Hotels (North) Limited through a preferential allotment of 63,74,057 equity shares. The shares were issued at a price of โน330 each, including a premium of โน320, resulting in a total capital infusion of approximately โน210.34 crore. This transaction was executed under SEBI's stressed company pricing norms (Regulation 164A), which exempts the acquirer from making a mandatory open offer. The entry of a Singapore-based institutional investor suggests a potential turnaround or strategic restructuring for the company.
Key Highlights
Acquisition of 63,74,057 equity shares representing 24.68% of the company's diluted share capital
Shares allotted at a price of โน330 per share, totaling an investment of โน210.34 crore
Acquisition completed via preferential issue between January 28 and January 30, 2026
Exempt from open offer requirements under Regulation 10(2B) of SEBI (SAST) Regulations
Post-transaction, Elana Holdings becomes a significant stakeholder from a zero-holding position
๐ผ Action for Investors
Investors should view this as a positive liquidity event and a valuation benchmark at โน330 per share. Monitor the company's upcoming financial results to see how this capital infusion impacts debt reduction and operational recovery.
Indian Hume Pipe Credit Rating Upgraded to 'IVR A/Stable' for Rs 1,850 Crore Bank Facilities
Infomerics Valuation and Rating Limited has upgraded the credit ratings for Indian Hume Pipe Company Limited's total bank facilities of Rs 1,850 crores. The long-term rating has been raised from IVR A- to IVR A with a stable outlook, while the short-term rating improved from IVR A2+ to IVR A1. This upgrade signifies an improved credit profile and stronger financial stability for the company. The rating action covers various facilities including long-term loans of Rs 623.25 crore and combined facilities of Rs 1,095 crore.
Key Highlights
Long-term bank facilities of Rs 623.25 crore upgraded to IVR A/Stable from IVR A-/Stable
Short-term bank facilities of Rs 90.00 crore upgraded to IVR A1 from IVR A2+
Combined Long/Short-term facilities of Rs 1,095.00 crore upgraded to IVR A/Stable/IVR A1
Total bank facilities reviewed and rated by Infomerics amount to Rs 1,850.00 crore
Upgrade reflects improved creditworthiness and potentially lower future borrowing costs
๐ผ Action for Investors
Investors should view this upgrade as a positive indicator of the company's strengthening balance sheet and financial health. The improved rating may lead to lower interest expenses, potentially boosting net margins in future quarters.
Asian Hotels (North) Allots 8.35 Lakh Shares to Elana Holdings at Rs 330/Share
Asian Hotels (North) Limited has finalized the allotment of 8,35,539 equity shares to Elana Holdings Pte. Ltd. on a preferential basis. The shares were issued at a price of Rs. 330 per share, which includes a premium of Rs. 320, raising approximately Rs. 27.57 crores. This move increases Elana Holdings' stake in the company from 12.34% to 15.52%. The total paid-up equity capital of the company has subsequently increased to Rs. 23.03 crores.
Key Highlights
Allotment of 8,35,539 equity shares at an issue price of Rs. 330 per share
Total capital infusion of Rs. 27,57,27,870 through preferential allotment
Elana Holdings Pte. Ltd. stake increased from 12.34% to 15.52%
Paid-up equity capital expanded from 2.22 crore shares to 2.30 crore shares
Issue price determined in compliance with Regulation 164A of SEBI ICDR Regulations
๐ผ Action for Investors
The capital infusion at a significant premium indicates strong investor confidence and improves the company's liquidity position. Investors should monitor the company's upcoming quarterly results to see how this capital is deployed for growth or debt reduction.
RBI Approves Re-appointment of Suresh Srinivasan Iyer as MD & CEO of Can Fin Homes for 2 Years
Can Fin Homes has received formal approval from the Reserve Bank of India (RBI) for the re-appointment of Shri Suresh Srinivasan Iyer as Managing Director & CEO. The extension is for a period of 2 years, effective from March 18, 2026. This regulatory clearance follows the Board's recommendation made on December 15, 2025. Leadership continuity at the top level is expected to provide stability to the company's strategic initiatives and operational performance.
Key Highlights
RBI approval granted on January 28, 2026, for the re-appointment of Shri Suresh Srinivasan Iyer.
The new term is for a duration of 2 years, commencing from March 18, 2026.
The appointment complies with Para 10 of RBI (Non-Banking Financial Companies - Governance) Directions, 2025.
The company will now seek necessary shareholder approval for the re-appointment within prescribed timelines.
๐ผ Action for Investors
Investors should view this as a positive development ensuring leadership stability. No immediate portfolio changes are required as the company maintains its current strategic path.
Asian Hotels (North) Allots 27.37 Lakh Shares to Elana Holding; Raises Rs 90.34 Cr
Asian Hotels (North) Limited has completed the allotment of 27,37,500 equity shares on a preferential basis to Elana Holding PTE Ltd. The shares were issued at a price of Rs. 330 per share, including a premium of Rs. 320, resulting in a total capital infusion of Rs. 90.34 crores. This allotment gives Elana Holding PTE Ltd a 12.34% stake in the company. Consequently, the company's paid-up equity capital has increased from Rs. 19.45 crore to Rs. 22.19 crore.
Key Highlights
Allotment of 27,37,500 equity shares at an issue price of Rs. 330 per share
Total fundraise of Rs. 90,33,75,000 through preferential allotment to Elana Holding PTE Ltd
Elana Holding PTE Ltd now holds a 12.34% post-allotment stake in the company
Paid-up equity capital increased from 1,94,53,229 shares to 2,21,90,729 shares
๐ผ Action for Investors
Investors should view this capital infusion as a positive sign of institutional interest and improved liquidity. Monitor the company's upcoming disclosures to see if the funds are utilized for debt reduction or property upgrades.
Canara HSBC Life Q3 FY26: VNB Jumps 37% YoY to โน413 Cr with 19.7% Margin
Canara HSBC Life reported a robust 9M FY26 performance with individual weighted premium income growing 20% YoY, significantly outperforming the private industry average of 13%. The Value of New Business (VNB) surged 37% to โน413 crores, supported by a 200 bps margin expansion to 19.7% despite GST and labor code impacts. Adjusted Profit After Tax (PAT) rose 19% YoY to โน101 crores, excluding a one-off labor code provision. The company is actively diversifying its distribution mix by launching an agency channel and plans to raise โน250 crores in subordinate debt to fuel further growth.
Key Highlights
Individual Weighted Premium Income (WPI) grew 20% YoY for 9M FY26, with Q3 growth accelerating to 29%.
VNB Margin improved to 19.7%, driven by higher rider attachments in ULIPs and 50% growth in the Credit Life segment.
13-month persistency ratio improved to 85.6% from 82.5%, while the total expense ratio decreased by 130 bps to 18.7%.
Indian Embedded Value (IEV) reached โน6,868 crores, representing a 17% year-on-year increase.
Board approved raising โน250 crores through subordinate debt to strengthen solvency and support channel expansion.
๐ผ Action for Investors
Investors should view the margin expansion and outperformance relative to the industry as strong indicators of operational efficiency. Monitor the scaling of the newly launched agency channel and the impact of subordinate debt on the company's long-term solvency and growth capacity.
Can Fin Homes Q3 FY26: Record INR 2,727 Cr Disbursements and Improved Asset Quality
Can Fin Homes reported its highest-ever quarterly disbursements of INR 2,727 crores, a 45% YoY increase, driven by recovery in Karnataka and Telangana. Net Interest Margin (NIM) improved to 4.14% due to a lag in passing on rate cuts, though the company has now transmitted 50 bps of the 100 bps RBI repo rate reduction to customers. Asset quality showed consistent improvement with SMA numbers declining, while the company maintains its full-year disbursement guidance of INR 10,500 crores. Elevated prepayments of INR 1,691 crores remain a headwind for AUM growth, which stood at approximately 9.5%.
Key Highlights
Achieved record quarterly disbursements of INR 2,727 crores, marking a 45% YoY and 7% QoQ growth.
Net Interest Margin (NIM) expanded to 4.14% from 4.02% in the previous quarter.
Delinquency levels improved for the fourth consecutive quarter, with SMA totals falling below INR 3,750 crores.
Passed on a cumulative 50 bps interest rate benefit to customers following the 100 bps RBI repo rate cut.
Maintained FY26 disbursement guidance of INR 10,500 crores despite elevated prepayments of INR 1,691 crores.
๐ผ Action for Investors
Investors should monitor the impact of the 50 bps rate transmission on future NIMs and the stabilization of prepayments. The strong disbursement momentum and improving asset quality in key markets like Telangana are positive indicators for long-term growth.
Canara HSBC Life 9M FY26: VNB Surges 37% to โน4,129 Mn; Margins Expand to 19.7%
Canara HSBC Life reported a robust performance for 9M FY26, highlighted by a 37% YoY growth in Value of New Business (VNB) to โน4,129 Mn. Total premium income grew 32% YoY to โน69,314 Mn, driven by strong growth in both new business and renewal premiums. While reported PAT grew 8% to โน919 Mn, the underlying profit growth was 19% after adjusting for a one-time labor code impact. The company also achieved significant improvements in persistency across all cohorts and expanded its VNB margins to 19.7%.
Key Highlights
Value of New Business (VNB) increased 37% YoY to โน4,129 Mn with margins expanding to 19.7% from 17.6%.
Total Premium income rose 32% YoY to โน69,314 Mn, while Assets Under Management (AUM) grew 17% to โน469 Bn.
13th-month persistency improved to 85.6% from 83.4% YoY, indicating higher quality of business retention.
Embedded Value (IEV) stood at โน68,678 Mn as of Dec 2025, up from โน61,107 Mn in March 2025.
Total Expense Ratio improved to 18.7% from 20.0% in the previous year, reflecting better operational efficiency.
๐ผ Action for Investors
Investors should take note of the strong VNB growth and margin expansion which signal healthy profitability. The company's heavy reliance on Bancassurance (93%) remains a concentration risk, so the progress of the newly launched Agency channel should be monitored.
Canara HSBC Life 9M FY26: VNB Jumps 36.8% to โน412.9 Cr, Protection Business Grows 126%
Canara HSBC Life reported a strong 9M FY26 performance with Value of New Business (VNB) growing 36.8% YoY to โน412.9 crore, supported by a margin expansion to 19.7%. Total premium income rose significantly by 31.6% to โน6,931.4 crore, driven by a massive 126% surge in the protection segment. While Profit After Tax (PAT) saw a modest 8.2% growth to โน91.9 crore, operational efficiency improved with the expense ratio dropping to 18.7%. The company also strengthened its distribution network through a new bancassurance partnership with Equitas Small Finance Bank.
Key Highlights
Value of New Business (VNB) increased 36.8% YoY to โน412.9 crore with margins improving to 19.7%.
Total Premium Income grew 31.6% YoY to โน6,931.4 crore, while Individual WPI rose 20.5% to โน1,915.3 crore.
Protection business grew by 126% YoY, significantly outperforming other segments.
13-month persistency ratio improved to 85.6% from 83.4% in the previous year.
Assets Under Management (AUM) reached โน46,888.8 crore, a 17.2% YoY increase.
๐ผ Action for Investors
Investors should view the robust VNB growth and margin expansion as positive indicators of long-term profitability. The significant shift towards high-margin protection products and improved persistency suggests strengthening business fundamentals.
Narayana Hrudayalaya Stakeholders Approve Merger with Meridian Medical Research & Hospital
Narayana Hrudayalaya (NH) has received near-unanimous approval from its shareholders and creditors for the Scheme of Arrangement to merge its subsidiary, Meridian Medical Research & Hospital Ltd, into the parent company. In the NCLT-convened meeting held on January 19, 2026, 100% of the votes polled by equity shareholders and secured creditors were in favor of the resolution. This merger is a strategic move to consolidate operations and streamline the corporate structure, pending final approval from the NCLT Bengaluru Bench.
Key Highlights
Equity shareholders approved the merger with 100% of votes in favor, representing 16.23 crore shares.
Secured creditors representing debt worth โน461.20 crore gave unanimous 100% approval for the scheme.
Unsecured trade creditors with an aggregate debt of โน85.08 crore also voted 100% in favor of the merger.
The scheme involves the amalgamation of Meridian Medical Research & Hospital Ltd (Transferor) into Narayana Hrudayalaya Ltd (Transferee).
The voting was conducted via remote e-voting and electronic voting during the NCLT-convened meetings.
๐ผ Action for Investors
Investors should take note of this successful milestone in the company's corporate restructuring process, which is expected to improve operational efficiency. No immediate action is required as the company awaits final legal sanction from the NCLT.
NH Stakeholders Unanimously Approve Merger with Meridian Medical Research & Hospital Ltd
Narayana Hrudayalaya (NH) has received near-unanimous approval from its stakeholders for the Scheme of Arrangement with Meridian Medical Research & Hospital Ltd. In the NCLT-convened meeting held on January 19, 2026, equity shareholders representing 16.23 crore votes (100% of votes polled) supported the merger. Secured creditors with debt worth โน461.20 crore and unsecured trade creditors with debt of โน85.08 crore also voted 100% in favor of the resolution. This approval marks a critical milestone in the legal consolidation process under the Companies Act.
Key Highlights
Equity shareholders approved the merger with 100% of votes in favor (16,23,30,045 votes).
Secured creditors representing โน461.20 crore of debt gave unanimous approval for the scheme.
Unsecured trade creditors representing โน85.08 crore also voted 100% in favor of the arrangement.
The meeting was conducted via Video Conferencing following the NCLT Bengaluru order dated December 2, 2025.
The scheme involves the merger of Meridian Medical Research & Hospital Ltd (Transferor) into Narayana Hrudayalaya Ltd (Transferee).
๐ผ Action for Investors
Investors should view this as a positive step toward corporate simplification and potential operational synergies. Monitor for the final NCLT sanction order to conclude the merger process.
Canara HSBC Life Q3 Net Premium Jumps 78% YoY; Board Approves โน250 Cr NCD Fundraise
Canara HSBC Life Insurance reported a robust 77.9% year-on-year growth in Net Premium Income to โน3,567.16 crore for the quarter ended December 31, 2025. While quarterly Profit After Tax saw a marginal decline to โน27.65 crore, the nine-month PAT grew by 8.2% to โน91.88 crore. The Board also approved a capital infusion of up to โน250 crore through subordinated debt (NCDs) to bolster its capital base. The company maintains a healthy solvency ratio of 191% and reported zero Non-Performing Assets (NPAs).
Key Highlights
Net Premium Income surged 77.9% YoY to โน3,56,716 Lakhs in Q3 FY26 compared to โน2,00,532 Lakhs in Q3 FY25.
Profit After Tax for the nine-month period ended Dec 2025 stood at โน9,188 Lakhs, up from โน8,489 Lakhs in the previous year.
Board approved raising up to โน250 crore via Non-convertible Debentures (NCDs) in the nature of subordinated debt.
Solvency ratio remains strong at 191%, significantly above the regulatory requirement of 150%.
Asset quality remains pristine with 0% Gross NPAs reported for the policyholders' fund.
๐ผ Action for Investors
Investors should take note of the exceptional top-line growth and the company's proactive steps to raise capital for expansion. The stable solvency margins and zero NPAs indicate a healthy balance sheet and strong operational management.
Canara HSBC Life Q3 PAT at โน27.65 Cr; Board Approves โน250 Cr Fundraise via NCDs
Canara HSBC Life reported a significant surge in Net Premium Income to โน3,567.16 crore for Q3 FY26, compared to โน2,005.32 crore in the same period last year. However, quarterly Profit After Tax (PAT) saw a marginal decline to โน27.65 crore from โน29.32 crore YoY. For the nine-month period ending December 2025, PAT grew by 8.2% to reach โน91.88 crore. To bolster its capital position, the board has approved raising up to โน250 crore through subordinated debt (NCDs) on a private placement basis.
Key Highlights
Net Premium Income for Q3 FY26 grew by 77.9% YoY to โน3,567.16 crore.
Profit After Tax for 9M FY26 increased to โน91.88 crore from โน84.89 crore in 9M FY25.
Board approved a fundraise of up to โน250 crore via Non-convertible Debentures (subordinated debt).
Solvency Ratio moderated to 181% as of December 31, 2025, compared to 215% in the previous year.
Expenses of Management (EOM) ratio improved to 16.3% in Q3 FY26 from 19.2% in Q3 FY25.
๐ผ Action for Investors
Investors should monitor the successful placement of the โน250 crore NCDs and its subsequent impact on shoring up the solvency ratio. While premium growth is exceptionally strong, the slight decline in quarterly PAT suggests a need to watch for underwriting margins and operating cost trends.
Asian Hotels (North) Receives In-Principle Approval for Rs 765 Cr Preferential Issue
Asian Hotels (North) Limited has received in-principle approval from both BSE and NSE for a major preferential issue of 2,31,80,000 equity shares. The shares are to be issued at a minimum price of Rs 330 per share, which implies a total capital infusion of at least Rs 764.94 crore. This significant fundraise is subject to standard regulatory conditions and compliance with SEBI ICDR regulations. The move is expected to strengthen the company's balance sheet and provide capital for strategic requirements.
Key Highlights
Received in-principle approval for the issuance of 2,31,80,000 equity shares on a preferential basis.
Minimum issue price set at Rs 330 per share, totaling a fundraise of approximately Rs 764.94 crore.
Approvals obtained from both National Stock Exchange (NSE) and BSE Limited on January 19, 2026.
Company must ensure compliance with SEBI ICDR regulations regarding lock-ins and trading restrictions for allottees.
๐ผ Action for Investors
Investors should monitor the final allotment details and the company's disclosure regarding the specific utilization of these funds. While the capital infusion is positive, shareholders should consider the potential equity dilution resulting from the issuance of over 2.3 crore new shares.
Can Fin Homes Releases Q3 FY26 Earnings Call Recording and Management Commentary
Can Fin Homes Limited conducted its Q3 FY26 earnings call on January 19, 2026, featuring top management including the MD & CEO and CFO. The discussion centered on the company's financial performance, loan book growth, and asset quality for the third quarter. Key metrics such as Net Interest Margin (NIM), spreads, and future expansion plans were addressed to provide clarity on the company's trajectory. The company has made the full audio recording available for public review to ensure transparency regarding its business outlook.
Key Highlights
Earnings call for Q3 FY26 held on January 19, 2026, moderated by Investec Capital Services.
Management discussed critical metrics including NIM, spreads, and loan book growth for the quarter.
Focus areas included asset quality, provisioning, and geographical expansion strategies.
Audio recording of the 80-minute session has been made available via a public link for investor access.
๐ผ Action for Investors
Investors should listen to the recording to understand management's guidance on NIM and asset quality trends. Monitor the stock for reactions to specific commentary on growth targets and provisioning for the upcoming quarters.
NH Shareholders and Creditors Meet to Approve Merger with Meridian Medical Research
Narayana Hrudayalaya (NH) conducted meetings for its equity shareholders and various classes of creditors on January 19, 2026, to approve the merger of its subsidiary, Meridian Medical Research & Hospital Ltd., into the parent company. The meetings were held following an NCLT order dated December 2, 2025, and included remote e-voting as well as voting during the sessions. While the final voting results are expected by January 21, 2026, the proceedings indicate steady progress toward streamlining the corporate structure. This amalgamation is a strategic internal restructuring aimed at improving operational efficiency and reducing administrative costs.
Key Highlights
Meetings of shareholders and three creditor classes held on Jan 19, 2026, to approve the Scheme of Arrangement.
The scheme involves the amalgamation of subsidiary Meridian Medical Research & Hospital Ltd. with Narayana Hrudayalaya Ltd.
Remote e-voting was conducted from Jan 16 to Jan 18, 2026, with additional voting facilities provided during the meetings.
Final voting results are scheduled to be submitted to stock exchanges by January 21, 2026.
The merger process follows the NCLT Bengaluru Bench order dated December 2, 2025.
๐ผ Action for Investors
Investors should monitor the final voting results on January 21, 2026, to confirm the formal approval of the merger. This internal restructuring is a positive move for long-term administrative efficiency and corporate simplification.
NH Shareholders and Creditors Meet to Approve Merger with Meridian Medical Research
Narayana Hrudayalaya (NH) conducted court-convened meetings for its equity shareholders and three classes of creditors on January 19, 2026, to approve the amalgamation of its subsidiary, Meridian Medical Research & Hospital Ltd. The merger process follows the NCLT Bengaluru order dated December 2, 2025, aimed at consolidating hospital operations. While the final voting results are expected by January 21, 2026, the meeting proceedings were completed successfully via video conferencing. This restructuring is a strategic move to simplify the corporate structure and potentially improve operational efficiencies.
Key Highlights
Meetings held on Jan 19, 2026, for Shareholders, Secured Creditors, and Unsecured Creditors.
Proposed amalgamation of subsidiary Meridian Medical Research & Hospital Ltd. into Narayana Hrudayalaya Ltd.
The merger process is being executed under the directions of the Hon'ble NCLT, Bengaluru Bench.
Final voting results for the Scheme of Arrangement are to be submitted to exchanges by Jan 21, 2026.
The consolidation aims to streamline the group's healthcare assets and administrative functions.
๐ผ Action for Investors
Investors should look for the official voting results on January 21, 2026, to confirm the approval of the scheme. The merger is expected to be value-accretive through simplified corporate governance and tax efficiencies.
ICRA Reaffirms [ICRA]AA (Stable) Rating for Narayana Hrudayalaya's Rs 5,195 Cr Facilities
ICRA has reaffirmed Narayana Hrudayalaya's (NH) long-term credit rating at [ICRA]AA with a Stable outlook for facilities totaling Rs 5,195 crore. The company demonstrated strong financial performance with 15% YoY revenue growth in H1 FY2026 and healthy operating margins of 23.5%. Despite a significant Rs 2,200 crore acquisition in the UK and a planned capex of approximately Rs 2,200 crore over FY2026-27, NH maintains a comfortable leverage profile with a TD/OPBITDA of 1.6x as of September 2025. The rating reflects NH's established brand equity and successful geographic diversification into international markets like the Cayman Islands and the UK.
Key Highlights
ICRA reaffirmed [ICRA]AA (Stable) and [ICRA]A1+ ratings for total bank facilities and NCDs worth Rs 5,195 crore.
Revenue grew 15% YoY in H1 FY2026 with robust operating profit margins maintained at 23.5%.
Acquired UK-based Practice Plus Group Hospitals for Rs 2,200 crore to diversify international revenue streams.
Aggressive capex plan of Rs 700-800 crore for FY2026 and Rs 1,400-1,450 crore for FY2027 for greenfield projects.
Financial metrics remain healthy with interest coverage at 8.7x and TD/OPBITDA improving to 1.6x as of Sept 2025.
๐ผ Action for Investors
Investors can take confidence in the rating reaffirmation which validates NH's ability to fund large-scale acquisitions and capex without severely compromising its credit profile. Key monitorables include the successful integration of the UK business and the impact of heavy gestation costs from new hospital projects on near-term consolidated margins.
Can Fin Homes Q3 FY26 Net Profit Rises 25% YoY to Rs 265 Crore; NIM Expands to 4.14%
Can Fin Homes reported a robust performance for Q3 FY26, with Net Profit growing 25% YoY to Rs 265 crore. The company's loan book expanded by 10% to reach Rs 40,693 crore, while disbursements for the nine-month period grew by 19% YoY. Key profitability metrics showed significant improvement, with Net Interest Margin (NIM) rising to 4.14% from 3.73% and ROA increasing to 2.55%. The company maintains a healthy liquidity position with an LCR of 332.60% and total provisions of Rs 505 crore.
Key Highlights
Net Profit increased by 25% YoY to Rs 265 crore, while PBT grew 27% to Rs 341 crore
Net Interest Margin (NIM) expanded significantly to 4.14% from 3.73% in the previous year
Loan assets grew 10% YoY to Rs 40,693 crore, with housing loans making up 73% of the book
Return on Equity (ROE) improved to 18.80% compared to 17.55% in the corresponding quarter last year
Total provisions stand at Rs 505 crore, including a management overlay of Rs 59 crore
๐ผ Action for Investors
Investors should view these results positively due to the strong margin expansion and double-digit profit growth. The stock remains a solid play in the housing finance sector with improving efficiency and healthy return ratios.